Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2011 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: The Dodgy Ticker who wrote (31)	12/31/2010 2:56:41 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 400

Well, ABT is more biotech these days than Amgen, and (e.g.) GILD is as pharma as Merck. Seems to me that, good year, he's shooting himself in foot... picks with relatively little leverage..... bad year, he's got soul. Feels ok to me, but I don't really care either. :-)

To: The Dodgy Ticker who wrote (31)	12/31/2010 3:02:56 PM
From: keokalani'nui	Respond to of 400

Will be a great game. Oregon beat everyone I care about this season, and everyone else, but have to admit grudgingly they are one athletic, electric, frightening team at a school that has had little to cheer for this time of year. Would not want to have to cover any one of their players 1 on 1. But Auburn--even their QB!-- can crush some bones. I'll enjoy it for whoever wins. The two could score 90 points. Appreciate your feedback in the picks. Let's see what others think, then have a ruling.